Spend less time wrangling data and more time uncovering opportunities with Bloomberg’s growing number of investment research data products. Purpose-built and curated for rigorous investment research, ...

Fate Therapeutics has announced encouraging initial data from the FT819 phase 1 autoimmunity study for people with moderate-to-severe systemic lupus erythematosus (SLE). The ongoing trial is ...

There’s a careful balance between privacy and personalization that marketers must master to create an effective customer engagement and retention strategy. Yet the dynamic digital marketing landscape ...